[On-demand]The 4th NextGen Conference 2014

China is changing from a big country to a powerful country in generics industry and there are lots of opportunities in this shift:

• Generics market continues to flourish, the global growth reached at 8% and in China it achieved at 25%.
• Pricing policy from NDRC and tender offer from health planning committee to generics which get through generics consistency evaluation.
• Diversified development of generics market, M&A of pharmacy, strategic cooperation and generics branding
• Biosimilar is on emerging market, more pharmaceutical companies are involved in biosimilar business……

At the same time, generics companies also face up with many challenges in the increasingly competitive market environment:

• Stricter of regulation from FDA&EU, the requirement of generics registration and application become higher
• More types of generics are included in generics consistency evaluation, generics quality requirements gradually improve
• High standard of generics brings about price fall of terminal product and cost raise, cost inflation is obvious for generics pharmacy
• Impurity control and dissolution rate comparing are still two big technological difficulties for generics
• More innovator pharma manufacturers march into generics, pharma IP become deeply and more requirements for formulation development……

The 4th NEXTGEN CHINA 2014 will gather all resource of CPhI global and essence of past three conferences, and explore regulatory, market & technology in generics to discuss and showcase evolving generics landscape & solutions.

6 Compelling Reasons to Attend:

• Delving into key trends of generics regulatory, market and technology
• Hearing in-depth presentations from 25+ global speakers under CPhI resources
• Covering 3 hot topics: updated regulatory environment, ever-changing market and alliance, evolving technology and commercialization
• Networking with and 120+ decision makers from pharmaceutical companies
• Benefiting from case studies from leading generic pharmacy of US, EU and India
• 15+ professional presentations and 2+ panel discussion, getting on-spot answers to your critical business and technical challenges

Who Should Attend?

Decision makers/R&D/QA，QC/Product Development/Regulatory Affairs/BD/Marketing 
From: Generics Manufacturers/Innovator Pharma Manufacturers/CRO,CMO/Ingredient & Material Suppliers/Equipment Suppiers/Government Associations/Analytical Laboratories